VB - Vanguard Small-Cap ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
138.49
-1.95 (-1.39%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close140.44
Open139.44
Bid0.00 x 900
Ask0.00 x 800
Day's Range138.00 - 140.59
52 Week Range137.80 - 166.03
Volume856,711
Avg. Volume697,206
Net Assets87.32B
NAV149.27
PE Ratio (TTM)N/A
Yield1.51%
YTD Return2.00%
Beta (3Y Monthly)1.20
Expense Ratio (net)0.05%
Inception Date2004-01-26
Trade prices are not sourced from all markets
  • Small-Cap ETFs & Stocks to Outperform This Holiday Season (Revised)
    Zacks13 days ago

    Small-Cap ETFs & Stocks to Outperform This Holiday Season (Revised)

    The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.

  • Small-Cap ETFs & Stocks to Outperform This Holiday Season
    Zacks18 days ago

    Small-Cap ETFs & Stocks to Outperform This Holiday Season

    The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.

  • 5 Low-Fee ETFs That Aren’t All That Great
    InvestorPlacelast month

    5 Low-Fee ETFs That Aren’t All That Great

    There is no doubt about it: when it comes to exchange-traded funds (ETFs), advisors and investors love the low-fee products. For several years, the top funds in terms of new assets added are low-fee ETFs. That trend is continuing in 2018.

  • ETF Trends2 months ago

    7 Stock ETFs to Play a Rate-Increase Cycle

    As the Federal Reserve normalizes its monetary policy with higher interest rates ahead, U.S. equities and stock ETFs may continue to strengthen in an improving economic environment. "The Fed tends to raise rates at times when it thinks the economy shows signs of overheating—to tighten credit and reduce the chance of rampant inflation. The outperformance is also most concentrated in smaller businesses and those in cyclical industries.

  • Investopedia3 months ago

    Top 3 Small-Cap ETFs for 2018

    There's a case to be made that small-cap ETFs will outperform in the months ahead. Here are a few to consider.

  • Reuters4 months ago

    Limited engagement - Top funds backed gunmaker Ruger board despite no talks

    Funds run by BlackRock Inc (BLK.N) and Vanguard Group backed all directors at gunmaker Sturm Ruger & Co Inc (RGR.N) despite the company's rare rejection of talks with the world's top asset managers, disclosures to regulators on Thursday showed. The votes by the gunmaker's largest investors stood in contrast to support BlackRock and Vanguard gave to a measure calling on Sturm Ruger to report on the safety of its products, which passed over the board's objections at the company's annual meeting on May 9. Neither BlackRock nor Vanguard would discuss in detail their votes at the meeting.

  • 5 Ridiculously Low-Cost ETFs
    InvestorPlace4 months ago

    5 Ridiculously Low-Cost ETFs

    For investors that like inexpensive funds, index funds and exchange traded funds (ETFs) are the primary destinations. There are plenty of low-cost ETFs on the market today and with issuers showing a willingness to trim fees, it is likely more funds will be labeled low-cost ETFs in the future.

  • Investopedia6 months ago

    Top 3 Small-Cap ETFs for 2018

    There's a case to be made that small-cap ETFs will outperform in the months ahead. Here are a few to consider.

  • How to Invest with Confidence
    Zacks10 months ago

    How to Invest with Confidence

    Did the recent stock market correction give you jitters? You're not alone. Find out how to take charge of your investing.

  • ETF Trends10 months ago

    Rising Interest Rates Does Not Spell Doom for Stock ETFs

    The Federal Reserve typically hikes interest rates to obviate an overheating economy during the later stages of an economic cycle, typically foreshadowing the eventual end of a bull market. Nevertheless, ...

  • Taking Stock of Globus Medical’s Recent Acquisitions
    Market Realist10 months ago

    Taking Stock of Globus Medical’s Recent Acquisitions

    Globus Medical (GMED) recently launched a robotic surgical navigation device. Since its inception in 2003, Globus Medical has launched more than 180 products. Globus Medical acquired KB Medical, a Switzerland-based robotic developer, in June 2017.

  • Investopedia11 months ago

    Top 3 Small-Cap ETFs for 2018

    There's a case to be made that small-cap ETFs will outperform in the months ahead. Here are a few to consider.

  • A Deeper Look at Nektar Therapeutics’ Licensing Agreements
    Market Realist11 months ago

    A Deeper Look at Nektar Therapeutics’ Licensing Agreements

    Nektar Therapeutics (NKTR) has entered into a number of licensing and collaboration agreements for research, development, and commercialization with various healthcare companies, including Eli Lilly (LLY), AstraZeneca (AZN), and Amgen (AMGN). Under these agreements, Nektar is entitled to receive license fees, milestone payments, royalties, and payments for manufacturing and supplying Nektar’s proprietary PEGylation materials.